Legal & General Group’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,990
| Closed | -$151K | – | 3410 |
|
|
2022
Q4 | $151K | Buy |
6,990
+434
| +7% | +$9.38K | ﹤0.01% | 2703 |
|
|
2022
Q3 | $127K | Buy |
6,556
+219
| +3% | +$4.24K | ﹤0.01% | 2756 |
|
|
2022
Q2 | $126K | Buy |
6,337
+218
| +4% | +$4.34K | ﹤0.01% | 2791 |
|
|
2022
Q1 | $183K | Buy |
6,119
+531
| +10% | +$15.9K | ﹤0.01% | 2705 |
|
|
2021
Q4 | $130K | Hold |
5,588
| – | – | ﹤0.01% | 2851 |
|
|
2021
Q3 | $175K | Buy |
5,588
+3,022
| +118% | +$94.6K | ﹤0.01% | 2729 |
|
|
2021
Q2 | $90K | Sell |
2,566
-266
| -9% | -$9.33K | ﹤0.01% | 2776 |
|
|
2021
Q1 | $100K | Buy |
2,832
+149
| +6% | +$5.26K | ﹤0.01% | 2620 |
|
|
2020
Q4 | $100K | Buy |
2,683
+1,193
| +80% | +$44.5K | ﹤0.01% | 2590 |
|
|
2020
Q3 | $50K | Sell |
1,490
-510
| -26% | -$17.1K | ﹤0.01% | 2699 |
|
|
2020
Q2 | $53K | Sell |
2,000
-61
| -3% | -$1.62K | ﹤0.01% | 2713 |
|
|
2020
Q1 | $34K | Sell |
2,061
-303
| -13% | -$5K | ﹤0.01% | 2732 |
|
|
2019
Q4 | $60K | Buy |
2,364
+421
| +22% | +$10.7K | ﹤0.01% | 2750 |
|
|
2019
Q3 | $39K | Buy |
1,943
+310
| +19% | +$6.22K | ﹤0.01% | 2846 |
|
|
2019
Q2 | $53K | Hold |
1,633
| – | – | ﹤0.01% | 2763 |
|
|
2019
Q1 | $53K | Buy |
1,633
+274
| +20% | +$8.89K | ﹤0.01% | 2697 |
|
|
2018
Q4 | $33K | Hold |
1,359
| – | – | ﹤0.01% | 2870 |
|
|
2018
Q3 | $45K | Hold |
1,359
| – | – | ﹤0.01% | 2828 |
|
|
2018
Q2 | $48K | Buy |
+1,359
| New | +$48K | ﹤0.01% | 2772 |
|